{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["allergy", "asthma", "budesonide", "ozone", "surfactant protein-D"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "31572383", "DateCompleted": {"Year": "2020", "Month": "10", "Day": "26"}, "DateRevised": {"Year": "2022", "Month": "02", "Day": "21"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2019", "Month": "09", "Day": "13"}], "ELocationID": ["2173", "10.3389/fimmu.2019.02173"], "Journal": {"ISSN": "1664-3224", "JournalIssue": {"Volume": "10", "PubDate": {"Year": "2019"}}, "Title": "Frontiers in immunology", "ISOAbbreviation": "Front Immunol"}, "ArticleTitle": "Ozone Inhalation Attenuated the Effects of Budesonide on <i>Aspergillus fumigatus</i>-Induced Airway Inflammation and Hyperreactivity in Mice.", "Pagination": {"StartPage": "2173", "MedlinePgn": "2173"}, "Abstract": {"AbstractText": ["Inhaled glucocorticoids form the mainstay of asthma treatment because of their anti-inflammatory effects in the lung. Exposure to the air pollutant ozone (O<sub>3</sub>) exacerbates chronic airways disease. We and others showed that presence of the epithelial-derived surfactant protein-D (SP-D) is important in immunoprotection against inflammatory changes including those induced by O<sub>3</sub> inhalation in the airways. SP-D synthesis requires glucocorticoids. We hypothesized here that O<sub>3</sub> exposure impairs glucocorticoid responsiveness (including SP-D production) in allergic airway inflammation. The effects of O<sub>3</sub> inhalation and glucocorticoid treatment were studied in a mouse model of allergic asthma induced by sensitization and challenge with <i>Aspergillus fumigatus</i> (<i>Af</i>) <i>in vivo</i>. The role of O<sub>3</sub> and glucocorticoids in regulation of SP-D expression was investigated in A549 and primary human type II alveolar epithelial cells <i>in vitro</i>. Budesonide inhibited airway hyperreactivity, eosinophil counts in the lung and bronchoalveolar lavage (BAL) and CCL11, IL-13, and IL-23p19 release in the BAL of mice sensitized and challenged with <i>Af</i> (<i>p</i> < 0.05). The inhibitory effects of budesonide were attenuated on inflammatory changes and were completely abolished on airway hyperreactivity after O<sub>3</sub> exposure of mice sensitized and challenged with <i>Af</i>. O<sub>3</sub> stimulated release of pro-neutrophilic mediators including CCL20 and IL-6 into the airways and impaired the inhibitory effects of budesonide on CCL11, IL-13 and IL-23. O<sub>3</sub> also prevented budesonide-induced release of the immunoprotective lung collectin SP-D into the airways of allergen-challenged mice. O<sub>3</sub> had a bi-phasic direct effect with early (<12 h) inhibition and late (>48 h) activation of SP-D mRNA (<i>sftpd</i>) <i>in vitro</i>. Dexamethasone and budesonide induced <i>sftpd</i> transcription and translation in human type II alveolar epithelial cells in a glucocorticoid receptor and STAT3 (an IL-6 responsive transcription factor) dependent manner. Our study indicates that O<sub>3</sub> exposure counteracts the effects of budesonide on airway inflammation, airway hyperreactivity, and SP-D production. We speculate that impairment of SP-D expression may contribute to the acute O<sub>3</sub>-induced airway inflammation. Asthmatics exposed to high ambient O<sub>3</sub> levels may become less responsive to glucocorticoid treatment during acute exacerbations."], "CopyrightInformation": "Copyright \u00a9 2019 Flayer, Ge, Hwang, Kokalari, Redai, Jiang and Haczku."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Internal Medicine, University of California, Davis, Davis, CA, United States."}], "LastName": "Flayer", "ForeName": "Cameron H", "Initials": "CH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Internal Medicine, University of California, Davis, Davis, CA, United States."}, {"Identifier": [], "Affiliation": "Department of Internal Medicine, University of Pennsylvania, Philadelphia, PA, United States."}], "LastName": "Ge", "ForeName": "Moyar Q", "Initials": "MQ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Internal Medicine, University of Pennsylvania, Philadelphia, PA, United States."}], "LastName": "Hwang", "ForeName": "Jin W", "Initials": "JW"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Internal Medicine, University of Pennsylvania, Philadelphia, PA, United States."}], "LastName": "Kokalari", "ForeName": "Blerina", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Internal Medicine, University of Pennsylvania, Philadelphia, PA, United States."}], "LastName": "Redai", "ForeName": "Imre G", "Initials": "IG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Internal Medicine, University of California, Davis, Davis, CA, United States."}, {"Identifier": [], "Affiliation": "Department of Internal Medicine, University of Pennsylvania, Philadelphia, PA, United States."}, {"Identifier": [], "Affiliation": "Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, China."}], "LastName": "Jiang", "ForeName": "Zhilong", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Internal Medicine, University of California, Davis, Davis, CA, United States."}, {"Identifier": [], "Affiliation": "Department of Internal Medicine, University of Pennsylvania, Philadelphia, PA, United States."}], "LastName": "Haczku", "ForeName": "Angela", "Initials": "A"}], "GrantList": [{"GrantID": "T32 ES007059", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "RC1 ES018505", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "T32 HL007013", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "P51 OD011107", "Acronym": "OD", "Agency": "NIH HHS", "Country": "United States"}, {"GrantID": "R42 AI132012", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}, {"GrantID": "P30 ES023513", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "R01 AI072197", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}, {"GrantID": "R21 AI116121", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}, {"GrantID": "R41 AI132012", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Immunol", "NlmUniqueID": "101560960", "ISSNLinking": "1664-3224"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Allergens"}, {"RegistryNumber": "0", "NameOfSubstance": "Chemokine CCL11"}, {"RegistryNumber": "0", "NameOfSubstance": "Glucocorticoids"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-13"}, {"RegistryNumber": "0", "NameOfSubstance": "Oxidants, Photochemical"}, {"RegistryNumber": "0", "NameOfSubstance": "Pulmonary Surfactant-Associated Protein D"}, {"RegistryNumber": "51333-22-3", "NameOfSubstance": "Budesonide"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "A549 Cells"}, {"QualifierName": [], "DescriptorName": "Administration, Inhalation"}, {"QualifierName": ["immunology"], "DescriptorName": "Allergens"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["immunology"], "DescriptorName": "Aspergillus fumigatus"}, {"QualifierName": ["immunology", "prevention & control"], "DescriptorName": "Asthma"}, {"QualifierName": ["chemistry", "cytology"], "DescriptorName": "Bronchoalveolar Lavage Fluid"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Budesonide"}, {"QualifierName": [], "DescriptorName": "Cells, Cultured"}, {"QualifierName": ["metabolism"], "DescriptorName": "Chemokine CCL11"}, {"QualifierName": ["metabolism"], "DescriptorName": "Eosinophils"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Glucocorticoids"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["immunology", "prevention & control"], "DescriptorName": "Inflammation"}, {"QualifierName": ["metabolism"], "DescriptorName": "Interleukin-13"}, {"QualifierName": ["drug effects", "immunology", "pathology"], "DescriptorName": "Lung"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred BALB C"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Oxidants, Photochemical"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Ozone"}, {"QualifierName": ["genetics", "immunology", "metabolism"], "DescriptorName": "Pulmonary Surfactant-Associated Protein D"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Alangari AA. Corticosteroids in the treatment of acute asthma. Ann Thorac Med. (2014) 9:187\u201392. 10.4103/1817-1737.140120", "ArticleIdList": ["10.4103/1817-1737.140120", "PMC4166064", "25276236"]}, {"Citation": "Barnes PJ. Glucocorticosteroids. Handb Exp Pharmacol. (2017) 237:93\u2013115. 10.1007/164_2016_62", "ArticleIdList": ["10.1007/164_2016_62", "27796513"]}, {"Citation": "Haczku A, Alexander A, Brown P, Assoufi B, Li B, Kay AB, et al. . The effect of dexamethasone, cyclosporine, and rapamycin on T-lymphocyte proliferation in vitro: comparison of cells from patients with glucocorticoid-sensitive and glucocorticoid-resistant chronic asthma. J Allergy Clin Immunol. (1994) 93:510\u20139. 10.1016/0091-6749(94)90361-1", "ArticleIdList": ["10.1016/0091-6749(94)90361-1", "8120277"]}, {"Citation": "Leung DY, Szefler SJ. New insights into steroid resistant asthma. Pediatr Allergy Immunol. (1998) 9:3\u201312. 10.1111/j.1399-3038.1998.tb00293.x", "ArticleIdList": ["10.1111/j.1399-3038.1998.tb00293.x", "9560836"]}, {"Citation": "Trevor JL, Deshane JS. Refractory asthma: mechanisms, targets, and therapy. Allergy. (2014) 69:817\u201327. 10.1111/all.12412", "ArticleIdList": ["10.1111/all.12412", "PMC4279947", "24773466"]}, {"Citation": "Rodriguez JM, Monsalves-Alvarez M, Henriquez S, Llanos MN, Troncoso R. Glucocorticoid resistance in chronic diseases. Steroids. (2016) 115:182\u201392. 10.1016/j.steroids.2016.09.010", "ArticleIdList": ["10.1016/j.steroids.2016.09.010", "27643454"]}, {"Citation": "Wang M, Gao P, Wu X, Chen Y, Feng Y, Yang Q, et al. . Impaired anti-inflammatory action of glucocorticoid in neutrophil from patients with steroid-resistant asthma. Respir Res. (2016) 17:153. 10.1186/s12931-016-0462-0", "ArticleIdList": ["10.1186/s12931-016-0462-0", "PMC5112750", "27852250"]}, {"Citation": "Chan MT, Leung DY, Szefler SJ, Spahn JD. Difficult-to-control asthma: clinical characteristics of steroid-insensitive asthma. J Allergy Clin Immunol. (1998) 101:594\u2013601. 10.1016/S0091-6749(98)70165-4", "ArticleIdList": ["10.1016/S0091-6749(98)70165-4", "9600494"]}, {"Citation": "Hollingsworth JW, II, Cook DN, Brass DM, Walker JK, Morgan DL, Foster WM, et al. . The role of Toll-like receptor 4 in environmental airway injury in mice. Am J Respir Crit Care Med. (2004) 170:126\u201332. 10.1164/rccm.200311-1499OC", "ArticleIdList": ["10.1164/rccm.200311-1499OC", "15020293"]}, {"Citation": "Park JW, Taube C, Joetham A, Takeda K, Kodama T, Dakhama A, et al. . Complement activation is critical to airway hyperresponsiveness after acute ozone exposure. Am J Respir Crit Care Med. (2004) 169:726\u201332. 10.1164/rccm.200307-1042OC", "ArticleIdList": ["10.1164/rccm.200307-1042OC", "14701711"]}, {"Citation": "Park JW, Taube C, Swasey C, Kodama T, Joetham A, Balhorn A, et al. . Interleukin-1 receptor antagonist attenuates airway hyperresponsiveness following exposure to ozone. Am J Respir Cell Mol Biol. (2004) 30:830\u20136. 10.1165/rcmb.2003-0373OC", "ArticleIdList": ["10.1165/rcmb.2003-0373OC", "14754758"]}, {"Citation": "Johnston RA, Mizgerd JP, Shore SA. CXCR2 is essential for maximal neutrophil recruitment and methacholine responsiveness after ozone exposure. Am J Physiol Lung Cell Mol Physiol. (2005) 288:L61\u201367. 10.1152/ajplung.00101.2004", "ArticleIdList": ["10.1152/ajplung.00101.2004", "15361358"]}, {"Citation": "Joad JP, Kott KS, Bric JM, Peake JL, Plopper CG, Schelegle ES, et al. Structural and functional localization of airway effects from episodic exposure of infant monkeys to allergen and/or ozone. Toxicol Appl Pharmacol. (2006) 214:237\u201343. 10.1016/j.taap.2005.12.012", "ArticleIdList": ["10.1016/j.taap.2005.12.012", "16466656"]}, {"Citation": "Lu FL, Johnston RA, Flynt L, Theman TA, Terry RD, Schwartzman IN, et al. . Increased pulmonary responses to acute ozone exposure in obese db/db mice. Am J Physiol Lung Cell Mol Physiol. (2006) 290:L856\u201365. 10.1152/ajplung.00386.2005", "ArticleIdList": ["10.1152/ajplung.00386.2005", "16373670"]}, {"Citation": "Shore SA. Obesity and asthma: lessons from animal models. J Appl Physiol. (2006) 102:516\u201328. 10.1152/japplphysiol.00847.2006", "ArticleIdList": ["10.1152/japplphysiol.00847.2006", "17053103"]}, {"Citation": "Strickland MJ, Darrow LA, Klein M, Flanders WD, Sarnat JA, Waller LA, et al. . Short-term associations between ambient air pollutants and pediatric asthma emergency department visits. Am J Respir Crit Care Med. (2010) 182:307\u201316. 10.1164/rccm.200908-1201OC", "ArticleIdList": ["10.1164/rccm.200908-1201OC", "PMC2921597", "20378732"]}, {"Citation": "Delamater PL, Finley AO, Banerjee S. An analysis of asthma hospitalizations, air pollution, and weather conditions in Los Angeles County, California. Sci Total Environ. (2012) 425:110\u20138. 10.1016/j.scitotenv.2012.02.015", "ArticleIdList": ["10.1016/j.scitotenv.2012.02.015", "PMC4451222", "22475217"]}, {"Citation": "Bao A, Li F, Zhang M, Chen Y, Zhang P, Zhou X. Impact of ozone exposure on the response to glucocorticoid in a mouse model of asthma: involvements of p38 MAPK and MKP-1. Respir Res. (2014) 15:126. 10.1186/s12931-014-0126-x", "ArticleIdList": ["10.1186/s12931-014-0126-x", "PMC4196074", "25287866"]}, {"Citation": "Stevens WH, Adelroth E, Wattie J, Woolley MJ, Ellis R, Dahlback M, et al. . Effect of inhaled budesonide on ozone-induced airway hyperresponsiveness and bronchoalveolar lavage cells in dogs. J Appl Physiol. (1994) 77:2578\u201383. 10.1152/jappl.1994.77.6.2578", "ArticleIdList": ["10.1152/jappl.1994.77.6.2578", "7896594"]}, {"Citation": "Joad JP, Kott KS, Bric JM, Schelegle ES, Gershwin LJ, Plopper CG, et al. . The effects of inhaled corticosteroids on intrinsic responsiveness and histology of airways from infant monkeys exposed to house dust mite allergen and ozone. Toxicol Appl Pharmacol. (2008) 226:153\u201360. 10.1016/j.taap.2007.09.005", "ArticleIdList": ["10.1016/j.taap.2007.09.005", "17991502"]}, {"Citation": "Alexis NE, Lay JC, Haczku A, Gong H, Linn W, Hazucha MJ, et al. . Fluticasone propionate protects against ozone-induced airway inflammation and modified immune cell activation markers in healthy volunteers. Environ Health Perspect. (2008) 116:799\u2013805. 10.1289/ehp.10981", "ArticleIdList": ["10.1289/ehp.10981", "PMC2430237", "18560537"]}, {"Citation": "Vagaggini B, Taccola M, Cianchetti S, Carnevali S, Bartoli ML, Bacci E, et al. . Ozone exposure increases eosinophilic airway response induced by previous allergen challenge. Am J Respir Crit Care Med. (2002) 166:1073\u20137. 10.1164/rccm.2201013", "ArticleIdList": ["10.1164/rccm.2201013", "12379550"]}, {"Citation": "Vagaggini B, Cianchetti S, Bartoli M, Ricci M, Bacci E, Dente FL, et al. . Prednisone blunts airway neutrophilic inflammatory response due to ozone exposure in asthmatic subjects. Respiration. (2007) 74:61\u20138. 10.1159/000096078", "ArticleIdList": ["10.1159/000096078", "17028419"]}, {"Citation": "Horvath SM, Gliner JA, Folinsbee LJ. Adaptation to ozone: duration of effect. Am Rev Respir Dis. (1981) 123:496\u20139.", "ArticleIdList": ["7235372"]}, {"Citation": "Backus-Hazzard GS, Howden R, Kleeberger SR. Genetic susceptibility to ozone-induced lung inflammation in animal models of asthma. Curr Opin Allergy Clin Immunol. (2004) 4:349\u201353. 10.1097/00130832-200410000-00004", "ArticleIdList": ["10.1097/00130832-200410000-00004", "15349032"]}, {"Citation": "Haczku A, Atochina EN, Tomer Y, Chen H, Scanlon ST, Russo S, et al. . Aspergillus fumigatus-induced allergic airway inflammation alters surfactant homeostasis and lung function in BALB/c mice. Am J Respir Cell Mol Biol. (2001) 25:45\u201350. 10.1165/ajrcmb.25.1.4391", "ArticleIdList": ["10.1165/ajrcmb.25.1.4391", "11472974"]}, {"Citation": "Takeda K, Haczku A, Lee JJ, Irvin CG, Gelfand EW. Strain dependence of airway hyperresponsiveness reflects differences in eosinophil localization in the lung. Am J Physiol Lung Cell Mol Physiol. (2001) 281:L394\u2013402. 10.1152/ajplung.2001.281.2.L394", "ArticleIdList": ["10.1152/ajplung.2001.281.2.L394", "11435214"]}, {"Citation": "Kierstein S, Poulain FR, Cao Y, Grous M, Mathias R, Kierstein G, et al. . Susceptibility to ozone-induced airway inflammation is associated with decreased levels of surfactant protein D. Respir Res. (2006) 7:85. 10.1186/1465-9921-7-85", "ArticleIdList": ["10.1186/1465-9921-7-85", "PMC1488844", "16740162"]}, {"Citation": "Atochina EN, Beers MF, Tomer Y, Scanlon ST, Russo SJ, Panettieri RA, Jr, et al. . Attenuated allergic airway hyperresponsiveness in C57BL/6 mice is associated with enhanced surfactant protein. (SP)-D production following allergic sensitization. Respir Res. (2003) 4:15. 10.1186/1465-9921-4-15", "ArticleIdList": ["10.1186/1465-9921-4-15", "PMC314399", "14748931"]}, {"Citation": "Haczku A, Cao Y, Vass G, Kierstein S, Nath P, Atochina-Vasserman EN, et al. . IL-4 and IL-13 form a negative feedback circuit with surfactant protein-D in the allergic airway response. J Immunol. (2006) 176:3557\u201365. 10.4049/jimmunol.176.6.3557", "ArticleIdList": ["10.4049/jimmunol.176.6.3557", "16517724"]}, {"Citation": "Ge MQ, Kokalari B, Flayer CH, Killingbeck SS, Redai IG, Macfarlane AWT, et al. Cutting edge: role of NK cells and surfactant protein D in dendritic cell lymph node homing: effects of ozone exposure. J Immunol. (2016) 196:553\u20137. 10.4049/jimmunol.1403042", "ArticleIdList": ["10.4049/jimmunol.1403042", "PMC4707083", "26673133"]}, {"Citation": "Forbes LR, Haczku A. SP-D and regulation of the pulmonary innate immune system in allergic airway changes. Clin Exp Allergy. (2010) 40:547\u201362. 10.1111/j.1365-2222.2010.03483.x", "ArticleIdList": ["10.1111/j.1365-2222.2010.03483.x", "20447075"]}, {"Citation": "Yousefi S, Sharma SK, Stojkov D, Germic N, Aeschlimann S, Ge MQ, et al. . Oxidative damage of SP-D abolishes control of eosinophil extracellular DNA trap formation. J Leukoc Biol. (2018) 104:205\u201314. 10.1002/JLB.3AB1117-455R", "ArticleIdList": ["10.1002/JLB.3AB1117-455R", "PMC6450398", "29733456"]}, {"Citation": "Deterding RR, Shimizu H, Fisher JH, Shannon JM. Regulation of surfactant protein D expression by glucocorticoids in vitro and in vivo. Am J Respir Cell Mol Biol. (1994) 10:30\u20137. 10.1165/ajrcmb.10.1.8292379", "ArticleIdList": ["10.1165/ajrcmb.10.1.8292379", "8292379"]}, {"Citation": "Mariencheck W, Crouch E. Modulation of surfactant protein D expression by glucocorticoids in fetal rat lung. Am J Respir Cell Mol Biol. (1994) 10:419\u201329. 10.1165/ajrcmb.10.4.8136157", "ArticleIdList": ["10.1165/ajrcmb.10.4.8136157", "8136157"]}, {"Citation": "Rust K, Bingle L, Mariencheck W, Persson A, Crouch EC. Characterization of the human surfactant protein D promoter: transcriptional regulation of SP-D gene expression by glucocorticoids. Am J Respir Cell Mol Biol. (1996) 14:121\u201330. 10.1165/ajrcmb.14.2.8630261", "ArticleIdList": ["10.1165/ajrcmb.14.2.8630261", "8630261"]}, {"Citation": "Cao Y, Tao JQ, Bates SR, Beers MF, Haczku A. IL-4 induces production of the lung collectin surfactant protein-D. J Allergy Clin Immunol. (2004) 113:439\u201344. 10.1016/j.jaci.2003.11.031", "ArticleIdList": ["10.1016/j.jaci.2003.11.031", "15007344"]}, {"Citation": "Park SK, Dahmer MK, Quasney MW. MAPK and JAK-STAT signaling pathways are involved in the oxidative stress-induced decrease in expression of surfactant protein genes. Cell Physiol Biochem. (2012) 30:334\u201346. 10.1159/000339068", "ArticleIdList": ["10.1159/000339068", "22739240"]}, {"Citation": "Kierstein S, Krytska K, Sharma S, Amrani Y, Salmon M, Panettieri RA, Jr, et al. . Ozone inhalation induces exacerbation of eosinophilic airway inflammation and hyperresponsiveness in allergen-sensitized mice. Allergy. (2008) 63:438\u201346. 10.1111/j.1398-9995.2007.01587.x", "ArticleIdList": ["10.1111/j.1398-9995.2007.01587.x", "18315731"]}, {"Citation": "Yang Q, Ge MQ, Kokalari B, Redai IG, Wang X, Kemeny DM, et al. . Group 2 innate lymphoid cells mediate ozone-induced airway inflammation and hyperresponsiveness in mice. J Allergy Clin Immunol. (2016) 137:571\u20138. 10.1016/j.jaci.2015.06.037", "ArticleIdList": ["10.1016/j.jaci.2015.06.037", "PMC4747855", "26282284"]}, {"Citation": "Hatch GE, Slade R, Harris LP, Mcdonnell WF, Devlin RB, Koren HS, et al. . Ozone dose and effect in humans and rats. A comparison using oxygen-18 labeling and bronchoalveolar lavage. Am J Respir Crit Care Med. (1994) 150:676\u201383. 10.1164/ajrccm.150.3.8087337", "ArticleIdList": ["10.1164/ajrccm.150.3.8087337", "8087337"]}, {"Citation": "Slade R, Watkinson WP, Hatch GE. Mouse strain differences in ozone dosimetry and body temperature changes. Am J Physiol. (1997) 272:L73\u201377. 10.1152/ajplung.1997.272.1.L73", "ArticleIdList": ["10.1152/ajplung.1997.272.1.L73", "9038905"]}, {"Citation": "Atochina-Vasserman EN, Winkler C, Abramova H, Schaumann F, Krug N, Gow AJ, et al. . Segmental allergen challenge alters multimeric structure and function of surfactant protein D in humans. Am J Respir Crit Care Med. (2011) 183:856\u201364. 10.1164/rccm.201004-0654OC", "ArticleIdList": ["10.1164/rccm.201004-0654OC", "PMC3086753", "21131470"]}, {"Citation": "Atochina-Vasserman EN. S-nitrosylation of surfactant protein D as a modulator of pulmonary inflammation. Biochim Biophys Acta. (2012) 1820:763\u20139. 10.1016/j.bbagen.2011.12.006", "ArticleIdList": ["10.1016/j.bbagen.2011.12.006", "PMC4013789", "22183030"]}, {"Citation": "Mathew T, Sarada SKS. Intonation of Nrf2 and Hif1-alpha pathway by curcumin prophylaxis: a potential strategy to augment survival signaling under hypoxia. Respir Physiol Neurobiol. (2018) 258:12\u201324. 10.1016/j.resp.2018.09.008", "ArticleIdList": ["10.1016/j.resp.2018.09.008", "30268739"]}, {"Citation": "Schneberger D, Devasure JM, Kirychuk SA, Wyatt TA. Organic barn dust inhibits surfactant protein D production through protein kinase-c alpha dependent increase of GPR116. PLoS ONE. (2018) 13:e0208597. 10.1371/journal.pone.0208597", "ArticleIdList": ["10.1371/journal.pone.0208597", "PMC6292596", "30543664"]}, {"Citation": "Li S, Sun Z, Chen T, Pan J, Shen Y, Chen X, et al. . The role of miR-431-5p in regulating pulmonary surfactant expression in vitro. Cell Mol Biol Lett. (2019) 24:25. 10.1186/s11658-019-0150-4", "ArticleIdList": ["10.1186/s11658-019-0150-4", "PMC6446292", "30988675"]}, {"Citation": "Kelly EA, Busse WW, Jarjour NN. Inhaled budesonide decreases airway inflammatory response to allergen. Am J Respir Crit Care Med. (2000) 162:883\u201390. 10.1164/ajrccm.162.3.9910077", "ArticleIdList": ["10.1164/ajrccm.162.3.9910077", "10988100"]}, {"Citation": "Nuhoglu Y, Bahceciler NN, Barlan IB, Mujdat Basaran M. The effectiveness of high-dose inhaled budesonide therapy in the treatment of acute asthma exacerbations in children. Ann Allergy Asthma Immunol. (2001) 86:318\u201322. 10.1016/S1081-1206(10)63306-6", "ArticleIdList": ["10.1016/S1081-1206(10)63306-6", "11289332"]}, {"Citation": "Hill JM. Nebulised corticosteroids in the treatment of patients with asthma. Thorax. (1999) 54:661\u20133. 10.1136/thx.54.8.661", "ArticleIdList": ["10.1136/thx.54.8.661", "PMC1745539", "10413715"]}, {"Citation": "Zhang Y, He J, Yuan Y, Faramand A, Fang F, Ji H. Increased versus stable dose of inhaled corticosteroids for asthma exacerbations: a systematic review and meta-analysis. Clin Exp Allergy. (2019). 10.1111/cea.13450. [Epub ahead of print].", "ArticleIdList": ["10.1111/cea.13450.", "31206220"]}, {"Citation": "Alexis NE, Carlsten C. Interplay of air pollution and asthma immunopathogenesis: a focused review of diesel exhaust and ozone. Int Immunopharmacol. (2014) 23:347\u201355. 10.1016/j.intimp.2014.08.009", "ArticleIdList": ["10.1016/j.intimp.2014.08.009", "25194677"]}, {"Citation": "Vagaggini B, Taccola M, Conti I, Carnevali S, Cianchetti S, Bartoli ML, et al. Budesonide reduces neutrophilic but not functional airway response to ozone in mild asthmatics. Am J Respir Crit Care Med. (2001) 164:2172\u20136. 10.1164/ajrccm.164.12.2009090", "ArticleIdList": ["10.1164/ajrccm.164.12.2009090", "11751182"]}, {"Citation": "Hortobagyi L, Kierstein S, Krytska K, Zhu X, Das AM, Poulain F, et al. . Surfactant protein D inhibits TNF-alpha production by macrophages and dendritic cells in mice. J Allergy Clin Immunol. (2008) 122:521\u20138. 10.1016/j.jaci.2008.05.002", "ArticleIdList": ["10.1016/j.jaci.2008.05.002", "PMC4024109", "18554706"]}, {"Citation": "He Y, Crouch EC, Rust K, Spaite E, Brody SL. Proximal promoter of the surfactant protein D gene: regulatory roles of AP-1, forkhead box, and GT box binding proteins. J Biol Chem. (2000) 275:31051\u201360. 10.1074/jbc.M003499200", "ArticleIdList": ["10.1074/jbc.M003499200", "10915785"]}, {"Citation": "Zhang Z, Jones S, Hagood JS, Fuentes NL, Fuller GM. STAT3 acts as a co-activator of glucocorticoid receptor signaling. J Biol Chem. (1997) 272:30607\u201310. 10.1074/jbc.272.49.30607", "ArticleIdList": ["10.1074/jbc.272.49.30607", "9388192"]}, {"Citation": "Blaskovich MA, Sun J, Cantor A, Turkson J, Jove R, Sebti SM. Discovery of JSI-124. (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Cancer Res. (2003) 63:1270\u20139.", "ArticleIdList": ["12649187"]}, {"Citation": "O'byrne PM. Acute asthma intervention: insights from the STAY study. J Allergy Clin Immunol. (2007) 119:1332\u20131336. 10.1016/j.jaci.2007.03.007", "ArticleIdList": ["10.1016/j.jaci.2007.03.007", "17451803"]}, {"Citation": "Lin J, Zhou X, Wang C, Liu C, Cai S, Huang M. Symbicort(R) maintenance and reliever therapy (SMART) and the evolution of asthma management within the GINA guidelines. Expert Rev Respir Med. (2018) 12:191\u2013202. 10.1080/17476348.2018.1429921", "ArticleIdList": ["10.1080/17476348.2018.1429921", "29400090"]}, {"Citation": "Direkwattanachai C, Aksilp C, Chatchatee P, Jirapongsananuruk O, Kamalaporn H, Kamchaisatian W, et al. . Practical considerations of nebulized corticosteroid in children with acute asthmatic exacerbation: a consensus. Asian Pac J Allergy Immunol. (2019). 10.12932/AP-170918-0407. [Epub ahead of print].", "ArticleIdList": ["10.12932/AP-170918-0407.", "30660170"]}, {"Citation": "Health effects of outdoor air pollution Committee of the environmental and occupational health assembly of the american thoracic society. Am J Respir Crit Care Med. (1996) 153:3\u201350. 10.1164/ajrccm.153.1.8542133", "ArticleIdList": ["10.1164/ajrccm.153.1.8542133", "8542133"]}, {"Citation": "Li R, Jiang N, Liu Q, Huang J, Guo X, Liu F, et al. . Impact of air pollutants on outpatient visits for acute respiratory outcomes. Int J Environ Res Public Health. (2017) 14:47. 10.3390/ijerph14010047", "ArticleIdList": ["10.3390/ijerph14010047", "PMC5295298", "28067786"]}, {"Citation": "Wang X, Nelson A, Weiler ZM, Patil A, Sato T, Kanaji N, et al. . Anti-inflammatory effects of budesonide in human lung fibroblast are independent of histone deacetylase 2. J Inflamm Res. (2013) 6:109\u201319. 10.2147/JIR.S43736", "ArticleIdList": ["10.2147/JIR.S43736", "PMC3780291", "24062615"]}, {"Citation": "Stellato C, Matsukura S, Fal A, White J, Beck LA, Proud D, et al. . Differential regulation of epithelial-derived C-C chemokine expression by IL-4 and the glucocorticoid budesonide. J Immunol. (1999) 163:5624\u201332.", "ArticleIdList": ["10553092"]}, {"Citation": "Bozinovski S, Uddin M, Vlahos R, Thompson M, Mcqualter JL, Merritt AS, et al. Serum amyloid A opposes lipoxin A(4) to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease. Proc Natl Acad Sci USA. (2012) 109:935\u201340. 10.1073/pnas.1109382109", "ArticleIdList": ["10.1073/pnas.1109382109", "PMC3271884", "22215599"]}, {"Citation": "Mattes J, Yang M, Siqueira A, Clark K, Mackenzie J, Mckenzie AN, et al. . IL-13 induces airways hyperreactivity independently of the IL-4R alpha chain in the allergic lung. J Immunol. (2001) 167:1683\u201392. 10.4049/jimmunol.167.3.1683", "ArticleIdList": ["10.4049/jimmunol.167.3.1683", "11466392"]}, {"Citation": "Zijlstra GJ, Fattahi F, Rozeveld D, Jonker MR, Kliphuis NM, Van Den Berge M, et al. . Glucocorticoids induce the production of the chemoattractant CCL20 in airway epithelium. Eur Respir J. (2014) 44:361\u201370. 10.1183/09031936.00209513", "ArticleIdList": ["10.1183/09031936.00209513", "24627531"]}, {"Citation": "Fahy JV. Eosinophilic and neutrophilic inflammation in asthma: insights from clinical studies. Proc Am Thorac Soc. (2009) 6:256\u20139. 10.1513/pats.200808-087RM", "ArticleIdList": ["10.1513/pats.200808-087RM", "19387026"]}, {"Citation": "Pelaia G, Vatrella A, Busceti MT, Gallelli L, Calabrese C, Terracciano R, et al. . Cellular mechanisms underlying eosinophilic and neutrophilic airway inflammation in asthma. Mediators Inflamm. (2015) 2015:879783. 10.1155/2015/879783", "ArticleIdList": ["10.1155/2015/879783", "PMC4386709", "25878402"]}, {"Citation": "Benfante A, Battaglia S, Principe S, Di Mitri C, Paterno A, Spatafora M, et al. . Asthmatics with high levels of serum surfactant protein D have more severe disease. Eur Respir J. (2016) 47:1864\u20137. 10.1183/13993003.02142-2015", "ArticleIdList": ["10.1183/13993003.02142-2015", "26989101"]}, {"Citation": "Mackay RM, Grainge CL, Lau LC, Barber C, Clark HW, Howarth PH. Airway surfactant protein D deficiency in adults with severe asthma. Chest. (2016) 149:1165\u201372. 10.1016/j.chest.2015.11.012", "ArticleIdList": ["10.1016/j.chest.2015.11.012", "PMC4944769", "26836907"]}, {"Citation": "Sims MW, Tal-Singer RM, Kierstein S, Musani AI, Beers MF, Panettieri RA, et al. . Chronic obstructive pulmonary disease and inhaled steroids alter surfactant protein D (SP-D) levels: a cross-sectional study. Respir Res. (2008) 9:13. 10.1186/1465-9921-9-13", "ArticleIdList": ["10.1186/1465-9921-9-13", "PMC2249580", "18226251"]}, {"Citation": "Guo CJ, Atochina-Vasserman EN, Abramova E, Foley JP, Zaman A, Crouch E, et al. . S-nitrosylation of surfactant protein-D controls inflammatory function. PLoS Biol. (2008) 6:e266. 10.1371/journal.pbio.0060266", "ArticleIdList": ["10.1371/journal.pbio.0060266", "PMC2581630", "19007302"]}, {"Citation": "Fei X, Zhang PY, Zhang X, Zhang GQ, Bao WP, Zhang YY, et al. . IL-17A monoclonal antibody partly reverses the glucocorticoids insensitivity in mice exposed to ozonec. Inflammation. (2017) 40:788\u201397. 10.1007/s10753-017-0523-7", "ArticleIdList": ["10.1007/s10753-017-0523-7", "PMC5429348", "28194607"]}], "ReferenceList": []}], "History": [{"Year": "2019", "Month": "1", "Day": "4"}, {"Year": "2019", "Month": "8", "Day": "28"}, {"Year": "2019", "Month": "10", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "10", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "10", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["31572383", "PMC6753328", "10.3389/fimmu.2019.02173"]}}], "PubmedBookArticle": []}